Home / Products / Cancer (Tumor) Cell Lines / FaDu
FaDu
Datasheet Protocol

FaDu

Cat. No. ARC0206
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Pharynx (hypopharynx)

Growth Properties:

Adherent

In stock
$1,300.00 / Vial
Ask a Question

Short Description 🔒

FaDu is a cancer cell line of pharynx (hypopharynx) squamous cell carcinoma, isolated from in situ; hypopharynx.

Recommended Products

GALNT7 Knockout jurkat Polyclonal Cells GALNT7 Knockout jurkat Polyclonal Cells Cat. No. ARG13532 ARPC1A Knockout A2780 Polyclonal Cells ARPC1A Knockout A2780 Polyclonal Cells Cat. No. ARG28799 ATAD3A Knockout MCF7 Polyclonal Cells ATAD3A Knockout MCF7 Polyclonal Cells Cat. No. ARG36420 CA2 Knockout Raji Polyclonal Cells CA2 Knockout Raji Polyclonal Cells Cat. No. ARG41647 GAA Knockout HCT116 Polyclonal Cells GAA Knockout HCT116 Polyclonal Cells Cat. No. ARG6979 NDUFA12 Knockout HEK293T Polyclonal Cells NDUFA12 Knockout HEK293T Polyclonal Cells Cat. No. ARG3440
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Pharynx (hypopharynx)
Disease:
Squamous cell carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
56 years
Sex of Donor:
Male
Derived From Site:
In situ; Hypopharynx
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

CIC Knockout SK-HEP-1 Polyclonal Cells

CIC Knockout SK-HEP-1 Polyclonal Cells

Cat. No. ARG16183
 HHEX Knockout HAP1 Polyclonal Cells

HHEX Knockout HAP1 Polyclonal Cells

Cat. No. ARG22512
 ABCG2 Knockout 786-O Polyclonal Cells

ABCG2 Knockout 786-O Polyclonal Cells

Cat. No. ARG24767
 ATP13A2 Knockout HEK293T Polyclonal Cells

ATP13A2 Knockout HEK293T Polyclonal Cells

Cat. No. ARG25791
 GSK3A Knockout HAP1 Polyclonal Cells

GSK3A Knockout HAP1 Polyclonal Cells

Cat. No. ARG34583
 CRADD Knockout MES-OV Polyclonal Cells

CRADD Knockout MES-OV Polyclonal Cells

Cat. No. ARG6012